Schwarzkopf owner Henkel has closed its acquisition of the epiCS skin model technology from SkinInVitro.
The closing was preceded by a successful technology transfer phase, which Henkel said guarantees the unchanged quality of epiCS production.
The models will now be manufactured at Henkel’s laboratories in Düsseldorf, Germany under the Phenion brand.
The epiCS technology includes reconstructed human epidermal equivalents, officially approved by the OECD for assessing the skin-corrosive potential (OECD TG 431) and – since April 2019 – the skin-irritating potential of chemicals (OECD TG 439).
Published by Cosmetics Business, November 3rd, 2020